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Abstract. There are statistical data indicating that diabetes is 
a risk factor for Parkinson's disease (PD). MethyJglyoxal (MG), 
a biologically reactive byproduct of glucose metabolism, the 
levels of which have been shown to be increase in diabetes, 
reacts with dopamine to form l-acetyl-6.7-dihydroxy-l 
tetrahydroisoquinoline (ADTIQ): this formation may provide 
further insight into the eonnection between PD and diabetes. 
In this study, we investigated the role of ADTIQ in these 
two diseases to determine in an aim to enhance our under-
standing of the link between PD and diabetes. To this end. a 
cell model of hyperglycemia and a rat model of diabetes were 
established. In the cell model of hyperglycemia. compared 
with the control group, the elevated glucose levels promoted 
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free hydroxyl radical formation (p<O.Ol). An ADTIQ assay 
was successfully developed and ADTIQ levels were detected 
and quantified. The levels of its precursors, MG and dopamine 
(DA), were determined in both the cell model of hyperglycemia 
and the rat model of diabetes. The proteins related to 
metabolism were also assayed. Compared with the control 
group, ADTIQ and MG levels were significantly elevated not 
only in the cell model of hyperglycemia, but also in the brains 
of rats with diabetes (p<O.OI). Seven key enzymes from the 
glycolytic pathway were found to be significantly more abun-
dant in the brains of rats with diabetes. Moreover, it was found 
that adenosine triphosphate (ATP) synthase and superoxide 
dismutase (SOD) expression levels were markedly decreased 
in the rats with diabetes compared with the control group. 
Therefore. ADTIQ expression levels were found to be elevated 
under hyperglycemic conditions. The results reported herein 
demonstrate that ADTIQ, which is derived from MG, the levels 
of which areincreased in diabetes, may serve as a neurotoxin to 
dopaminergie neurons, eventually leading to PD. 
Introduction 
Diabetes mellitus (DM), as a state of chronic hyperglycemia, 
and Parkinson's diseasc (PD) are diseases which eonsista 
health threat. In recent years. there have been increasing data 
indicating that hyperglycemia is associated with an increased 
risk of developing I'D (I However. the mechanisms under-
lying the association between hyperglycemia and I'D have not 
yet been elucidated, 
Deng and Rajpul (6) were the first to report, in 2001, 
that I -acetyl-6,7~di hydroxy-l ,2,3.4-tetrahydroisoqui noline 
(ADTlQ), a salsolinol-like compound, is found at 
concentrated levels in the brains of patients who suITer from 
PI) (3), When the brains of deceased patients with PD were 
compared to those of normal subjects. it was round that 
patients with I'D presented elevated levels of ADTIQ in all 
the examined brain areas. This finding indicated that "'C"u'~'" 
ADTIQ expression levels may be one of the 
involved in the increased risk patients with diabetes have of 
developing I'D 
.. 
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ADTIQ is an endogenous product acquired by a reac-
tion between methyl glyoxal (MG) and dopamine (DA). The 
reactive a-keto-aldehyde MG is the most important carbonyl, 
formed endogenously as a byproduct of the glycolytic pathway 
and formed either by the degradation of triosephosphates, or 
non-enzymatically by sugar fragmentation reactions (5). MG 
is gradually accumulated under hyperglycemic conditions , 
which may induce oxidative stress (6). 
The neurotoxi n, I-methyl-4-phenyl-l,2,3,6-tetrahydropyr-
idine (MPTP), is known to deplete striatal DA and to cause 
neuronal degeneration of the nigrostriatal pathway when 
administered to humans. The reason behind this, is that MPTP 
may induce oxidative stress and mitochondrial dysfunction, 
which can lead to PO (7). Catechol isoquinolines (CIQs) 
are considered to be naturally occurring MPTP-like neuro-
toxins. Salsolinol is demonstrated to be formed from DA and 
acetaldehyde by an (R)-salsolinol synthase-mediated conden-
sation, N-methylated into (R)-N-methylsalsolinol by a neutral 
(R)-salsolinol N-methyltransferase, and then oxidized into an 
ion of 6,7-dihydroxy-l,2-dimethyl-isoqiolinium, an analogue 
of I-methyl-4-phenylpyridinium (MPP'"). The toxicity of 
N-methylsalsolinol and its oxidation product for dopaminergic 
neurons has previously been examined in vivo and in vitro (8,9). 
The chemical structure of ADTIQ is very similar to that of 
salsolinol (Fig. 1). Therefore, in the current study, we hypoth-
esize that ADTIQ may be another endogenous neurotoxin with 
a possibly negative effect on the nervous system, which may 
cause damage to the peripheral, automatic and central nervous 
systems, and may ultimately lead to PD. 
In the present study, ADTIQ levels and those of its precursor, 
MG, were examined in a cell model of hyperglycemia and a rat 
model of diabetes. Proteomics was used to analyze the proteins 
involved, also analyzing their role in glucose metabolism. 
Materials and methods 
Cell line. The parental SH-SY5Y human neuroblastoma cell 
line was provided by Professor Wei-Hong Song (University of 
British Columbia). 
Animals. The study complied with the 'Guide for the Care 
and use of Laboratory Animals' published by the US National 
Institutes of Health (NIH publication no. 85-23, revised in 1985) 
and all animal experiments were approved by the Institutional 
Animal Research Advisory Committee of the Beijing Institute 
of Technology. Wi star rats (male , 180-200 g body weight, 
6-8 weeks old) and their granular food were provided by the 
Institute of Laboratory Animal Science, Chinese Academy of 
Medical Sciences (Beijing, China). The animals were main-
tained under a 12-h light/dark cycle at approximately 24±I°C 
and were allowed free access to food and water. 
Cell culture and establishment of the rat model of diabetes. 
The SH-SY5Y cells were grown under standard conditions in 
Dulbecco's modified Eagle's medium (DMEM) supplemented 
with 2 mM L-glutamine and 10% fetal calf serum at 3TC 
(5% CO2), 
A total of 40 Wi star rats were randomly divided into 
2 groups, a control group and a diabetes model group (10 rats 
in the control group and 30 rats in the model group). Baseline 
A 
'" 0 H H0X)! 
HO I #' NH, + CH'-~-~=o -
DA Methylglyoxal 
H 
I 
H-C= O 
--
DA Aldehyde 
HOX)) I #' / NH 
HO 
H 
I 
Salsolinol CH, 
Figure I. Reactions of methyl glyoxal and aldehydes with dopamine (DA). The 
chemical structure of l-acetyl-6,7-dihydroxy- I,2 ,3 ,4-tetrahydroisoquinoline 
(ADTIQ) is very similar to that of salsolinol. (A) DA reacts with methylgly-
oxal to produce ADTIQ; (B) DA reacts with aldehyde to produce salsolinol. 
blood glucose levels of all animals were measured after 12 h of 
fasting. Diabetes was induced by a single intraperitoneal injec-
tion of prepared streptozotocin (60 mg/kg body weight; Sigma, 
St. Louis , MO, USA) dissolved in sterile saline (0.85% NaCI). 
The control rats received an equal volume of the vehicle (normal 
saline). Non-fasting blood glucose levels were quantified a 
week later with the use of a commercially available glucometer. 
Streptozotocin-injected rats whose initial blood glucose levels 
were <300 mg/dl were considered as non-diabetic. Non-fasting 
blood glucose levels were monitored every 7th day during 
the course of the study and were examined again right before 
all the rats were anesthetized. The model group was fed for 
18 weeks in order to imitate chronic hyperglycemia induced by 
long-term injury to the nervous system. 
Measurement of free hydroxyl radicals in SH-SY5Y cells 
by high-performance liquid chromatography (HPLC)-
electrochemical detector (ECD) assay. The SH-SY5Y cells 
were exposed to 60 mM glucose (10). After 48 h, the cells 
were harvested and 200 ~I 10 mM ortho-oxybenzoic were 
added to the cells. The cells were lysed by sonication (50 cycles 
of 10 sec), centrifuged at 16,000 x g WC, 10 min) following 
incubation with 0.4 M PCA (l:2/v:v) for 30 min, and passed 
through a 0.22-~m filter membrane prior to analysis. All these 
samples were analyzed by HPLC-ECD using a CoulArray 
Electrochemical Detector (Model 5600A; ESA , USA) under 
the following conditions: i) the organic phase consisted of 10% 
methanol diluted in water (solvent A) ; ii) the balanced solution 
contained 35 mM citric acid , 45 mM sodium acetate, 0.l3 mM 
Na2EDTA, 0.2 mM SHS water-solution, pH 4.0 (solvent B); 
while iii) for the stationary phase, Alltima C I8 (4.6xI50 mm , 
5 ~m) analytical column was used . The column had a flow rate 
of 1 mllmin, it reached a temperature of 30°C, while its electric 
potential was: -50, 50, 300, 450, 650, 780, 900 mY. The volume 
of the sample used was 40 ~1. 
Detection of MG and ADTlQ in hyperglycemic cells and rats 
with diabetes by liquid chromatography (LC)-mass spectrom-
etry (MS) . LC-MS for the detection of MG and ADTIQ was 
carried out as previously described (11,12) . The prepared cells 
and brain tissues were lysed by sonication (50 cycles of 10 sec) 
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and centrifuged at 16,000 x g wc, 10 min) following incuba-
tion with 0,4 M PCA (I:2/v:\') for 30 min, The supernatant was 
passed through a 0,22-ttm fi Iter membrane, O-phenylenediami ne 
(2 mM) was added to the samples followed by incubation f~)r I h 
at 3TC. As MG cannot be retained on columns, an indirect 
derivatization method was used to measure MG levels in the rat 
brains. MG reacted with o-phenylenediamine and the product, 
2-methylquinoxaline (2-MQ), was detected as a measure of 
MG content. Tissue samples were separated into 2 groups, one 
for derivatization and another for no derivatization. 
LC was performed with the discovery F5-SH column 
(4.6x250 mm, 5 ttm). The mobile phase consisted of 32(;lb 
methanol and 68% formic acid (pH 3,49), while the flow rate 
was 0.7 mllmin and the UV detection wave length 315 nm. 
The volume of the sample analyzed was 50 ftl. Mass spectrum 
analysis was performed under the following conditions: mode 
clectrospray ionization (ESI), positive ion mode; MS scanning: 
nebulizer pressure, 28 psi; drying gas flow rate, 8 IImin; scan-
ning range, 135-225 mh; and extracted ion chromatography 
(EIC), 145 (2-MQ) and 208 (ADTIQ). 
Protein extraction and trypsin digestion. The control and 
model rat brain specimens were prepared and lysed by sonica-
tion (50 cycles of 10 sec) in 300 ttl lysis buffer [8 M urea, 4% 
3-«3-cholam idopropyl)d i methylam monio)-I-propanesul fon ic 
acid (CHAPS), 10 mM dithiothreitol (DTT) and O'()9 g solid 
ureal. The homogenates were left at room temperature for I h 
after having been centrifuged at 20,000 x g for 60 min at 4C, 
and the supernatants were then collected as protein extracts. 
Protein concentration was determined by the Lowry method 
after dialysis. Proteins (500 Jig) were freeze-dried at -56'C 
under a vacuum, as previously described (13.14). 
Dcsiccated proteins were dissolved in 200 ttl buffer solution 
(8 M urea, 10 mM DTT and 50 mM NH4HCO\) and incubated 
at 3TC for 4 h. Subsequently, 5 ftl of iodoacetamide (I M) 
were added in order for thc alkylation reaction to occur in 
the dark for I h. The urea concentration was diluted in 500 Jtl 
NH4 HCO, (50 mM). Porcine trypsin (Promega, Madison, WI, 
USA) was added in a final enzyme to protein ratio of 1:20. 
Digestion was conducted at 3TC for 18 h. 
Peptide detectiofl and quantification b)' LC-ES/~time-ol­
flight (TOF) MS. The quantification of the peptide mixtures 
in limited amounts of rat brain tissues was carried out b) 
LC-ESI-TOF-MS (Agilent 6210 Time-or-Flight LC/MS 
System; Agilent Technologies, Inc., Santa Clara, CA, USA). 
Samples were separated by a column (4.6x250 mm, 5 Itm) 
in acetonitrile-O.l% formic acid (5:95) (mobile phase) with 
a flow rate of 0.8 pI/min for online enrichment. They were 
thcn analyzed by a Zorbax column {O.5x150 mm, 5 flm). 
The peptides \vere separated and analyzed completely within 
70 min. The ESI positive scanning range was 300-1,800 mh. 
Analysis peptides by LC-MSIA1S. The peptide mixtures 
were separated by chromatography and analyzed by ion trap 
mass spectrometry (Agilent 1100 series LC/MSD mass spec~ 
tmmeter: Agilent Technologies, Inc.) with the reversed-phase 
(RP) column (4.6x250 mm, 5 ttm), at a flow rate of a 0.8 mil 
min. Samples of proteolytic digests (80 ttl) were injected into 
the column and run with a linear gradient of 9SCj( solvent A 
(0.1% formic acid) to 10011e solvent B (acetonitrile) for a time 
period of 70 min and post run for another 10 min (14). 
Bioinformatics analysis. MassHunter and MassProfi 
analysis software provided by Agilent Technologies, Inc. were 
used in order to analyze the TOF data. Significantly 
tially expressed peptides were selected from the mass data, 
The same samples were analyzed by LC-TOF before 
were validated by LC-MS/MS. The mil. value of signifkantly 
di ffcrentially expressed peptides was preferentially 
for LC-MS/MS analysis. 
Trypsin cleaves proteins at the C terminus or ne 
and arginine residues, thereby generating a peptide mass 
fingerprint (PMF) that can be llsed to search databases. The 
MS/MS data were searched using the MASCOT tool (http:// 
www.matrixscienec.com: Matrix Science, London, UK). The 
threshold parametcr values for mass accuracy were 150 ppm 
and one miscleavage was allowed. The scarch was performed 
against rat protein sequences. PMFs from Ollr samples were 
compared to corresponding fingerprints from NCBInr (http:// 
ncbi.nih.gov/National Center for Biotechnical Information, 
Bcthesda, M D, USA), MSDB (csc-fserve.hh.med.ic.ac, 
uk/msdb.html/Proteonomics Department, Hammersmith 
Campus, Imperial College, London, UK) and EnsemblC 
(http://www.ensembl.org/Sanger Centre, Hinxton, UK) data-
bases in order to find matches with the virtual tryptic protein 
masses. Gene Ontology entries were retrieved based on the 
IPI data tiles from Swiss-Prot. Gene Ontology terms were 
mapped to Ontoglyph terms (http://61.50J38.118/GOI'act/) to 
provide a coarse-grained classification of gene function (15). 
Detection (Jl protein content western blot analysis, Brain 
homogenate expression levels of glyceraldehyde-3-phosphate 
dehydrogenase (GAPDH) and adenosinc triphosphate (ATP) 
synthase were determined by western blot analysis. First, the 
protcins were separated by SDS-PAGE,then electrotransfcrred 
(electrodes were attached and the power supply was set to 
100 Vat constant voltage t~)f I h at Finally, immunodetec-
tion was carried out as follows: thc membranes were stained, 
blocked and ,vashed, and then su~iected to first antibody and 
second antibody and detection for the target protein. 
Statistical analysis. SPSS 13.0 software (SPSS, Chicago, 
USA) was used for statistical analysis. Values are 
as the means ± standard deviation (SD). Data werc analyzed 
using one-way ANOVA, followed by a Student's two-tailed 
paired t-test for comparisons betwcen 2 groups. A P-value 
<0.05 was considered to indicate a statistically 
ditTerence. 
Results 
i'vleasllremenl radicals in 
Sl-f-SY5 Y cells. Sal icyl ic acid hydroxylation is a 
scavenger for free hydroxyl radicals. Thus, the 
ation products, 2,3-dihydroxybenzoic acid (2,3-DHBA) 
hydroxybenzoic acid (25-DHBA), were 
order to indirectlv evaluate the degree of oxidative stress 
Free hydroxyl radicals in the SH;SY5Y cells treated ,vith or 
without glucose were measured by HPLC-ECD assay. No 
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Figure 2. Measurement of free hydroxyl radicals [2,3-dihydroxybenzoic acid 
(2,3 -DHBA) and 2,5-DHBA] in cell model of hyperglycemia by HPLC-
elec trochemical detector (ECD) assay. A la rge quantity of free hyd roxyl 
radicals was detected in the cell s treated with 60 mM glucose, contrary to 
the control cell s where only slight amounts of 2,3-DHBA or 2,5-DH BA were 
detected. A total of 3x l06 celi s was used per culture plate . The results from 
3 separate experiments are expressed as the means ± standard deviation (SD). 
" p<O.OI , stati stica lly significant differences in relation to the control group. 
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Figure 3. LC-MS measurement of l -acetyl-6,7-dihydroxy- I,2,3 ,4-tetrahy-
droisoquinoline (A DTIQ) in hyperglycemic SH-SY5Y cell s. Q uantifi cation 
of A DT IQ concentration was based on the chromatog ram peak area. A total 
of3x I06celi s was used per culture plate. Results from 3 separate experiments 
are expressed as the means ± standard dev iation (SD). " p<O.OI , statisti cally 
signi fi cant diffe rences in relation to the control group. 
2,3-0HBA o r 2 ,5-0HBA express ion was detected in the 
cont rol ce ll s. However, the re was a la rge qua ntity of f ree 
hydroxyl radicals in the hyperglycemic cell s. Compared with 
the cell s in the control group , an elevated level of glucose 
markedl y promoted f ree hydroxyl radical fo rmation in the 
hy perglycemic cell s (p<O.Ol) (Fig. 2). 
Measurement of ADTlQ levels in the cell model of hypergly-
cemia. O nl y minimal amounts of A OTIQ were detected in the 
control group, contra ry to the large amount that was detected in 
the cell s treated with a final concentration of 60 mM glucose for 
2 h. Compared with the control group, we observed a significant 
inc rease in the express ion levels of AOTIQ in the neuronal 
SH- SY5Y cell s cultured under hyperglycemic conditions 
following a 2-h incubation period (p<O.Ol) (Fig. 3). 
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Fig ure 4 . LC-MS detection of 2-methylquinoxaline (2-MQ) and I-acetyl-
6 ,7-dihydroxy- 1 ,2,3,4-tetrahydroisoqui noline (ADTIQ) levels in the control 
and brains of rats with diabetes. 2-MQ represented the amount of methylg-
Iyoxal. Levels of 2-MQ and ADTIQ in the brai ns of rats with diabetes were 
hi gher than those in the control group. 2-MQ and ADT IQ concentrations 
were calculated based on chromatogram peak areas. Results from 3 separate 
experiments a re expressed as the means ± standard deviation (SD). " p<O.OI , 
statistica lly significant di ffe rences in relation to the control group 
Measurement of MG and ADTlQ levels in the brains of rats 
with diabetes. The abundance of MG can be indirectly deter-
mined by measuring the levels of 2-MQ (17). LC/MS analysis 
was conducted to determine whether AOTIQ accumulated in 
the bra ins of rats with diabetes. The results indicated that the 
bra ins of rats with diabetes rat had significantly higher levels 
of AOTIQ (p<O.Ol) compared with the control group (Fig. 4) . 
Measurement of relative protein levels in ra t brains. A 
proteomics approach was used to sea rch fo r differenti a ll y 
expressed proteins in the bra ins of rats with diabetes (Materia ls 
and methods). The results of this proteom ics and bioi nfo rmatics 
analysis revealed that, in compari son to the control group, the 
expression levels of 7 key enzymes from the glycolytic pathway 
were significantly increased in the brains of rats with diabetes, 
while the levels of AT P synthase, an enzyme from the ox idati ve 
phosphorylation pathway, and of those superox ide di smutase 
(SOD) were significantly decreased. Compared with the control 
group, the diabetes group had a higher rate of glycolysis and a 
lower rate of oxidative phosphorylation (Table l) . 
Two proteins, GAPOH a nd ATP synthase, were selected 
to be semi-quanti f ied by weste rn blot a na lys is in orde r to 
verify the re liability of the proteomics results . It was show n 
that, compared with the control group, the GAPOH content in 
the rats with diabetes was increased while the AT P synthase 
content was decreased . These results were consistent with 
the those from proteomics a na lysis. T hus, the compa ra-
ti ve proteomics analysis proved to be a feasi bl e a nd reliable 
approach for studying relati ve protein levels (Fig. 5). 
Discussion 
T he patholog ica l process of PO is compl ex, involving a 
number of di ffe rent fac tors, such as mi tochond rial dysfunc-
tion, abnormal protein aggregation, famili a l inheritance and 
excitotox ic ity (18) . A previous study demonstrated that CIQs, 
such as salsolinol and NM-sa lsoli nol a re promi sing endog-
enous neurotoxins that may lead to the development of PO (1 9). 
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Table L Expression profiles of nine proteins in the brains of the control rats and rats with diabetes. 
Database Sequence Control Diabetes 
No. Protein annotation accession no. coverage group group 
Hexokinase IBG3A 12 021±OJ)5 O,5I±Om 
2 Fruetose-bisphosphate aldolase ADRTA 7 o 33±(),() I O.72±O'{) 
3 Triosephosphate isomerase TPIS ~ RAr 6 o 27±O.08 O.77±O'()2 
4 Glyceraldehyde-3-phosphate dehydrogcnase DERf'G 16 O.16±Om o 54±OJJ4 
5 Phosphoglycerate mutase, brain rorm PMGB 14 O.14±O.O4 038±O.04 
6 Enolase ENOA 9 022±O.O2 O.42±O.O) 
7 Pyruvate kinase KPYI 7 O.25±O.O5 O,57±O.OI 
8 SOD DSRrN 9 055±O.O2 O.2I±O.OI 
9 AI'P synthase ATPB RAT 9 O.71±O.O2 027±O.O3 
Compared with eontrol group, the expression levels of the llrst seven genes 1-7) were inereased, while those of the last two genes 
8 and 9) were deereased signi/leantly. Protein expression levels are expresed as the means SD of the percentage integrated area (%) of 
peplides. SOD, superoxide dismutase; ATP, adenosine triphosphate; SD. standard deviation. 
Diabetic Control 
............... GAPDH 
............... p-actin 
Diabetic Control 
............... A TP synthase 
............... ,i-actin 
Figure 5. Western blot analysis of the expressioll of adenosine triphosphate 
(ATP) synthase and glyceraldehydc·3·phosphate dehydrogenase (GAPDH). 
GAPDH content in the rats with diabetes mellitus (DM) was increascd. while 
the content of ATP synthase was decreased compared with thc control group. 
The results were consistent with the results obtained from protcomics analysis. 
Thus. a 'vicious' cycle may be induced by CIQs. ADTlQ is 
structurally similar to salsolinol, and has been suggested to be 
a neurotoxin (20,2l). 
Glycolysis is a crucial process in DM and the most exten· 
sively investigated metabolic pathway (22). MG is an important 
byproduct in this pathway and its production is increased due to 
hyperglycemia. The formation of dihydroxyacetone phosphate 
and D-glyeeraldehyde-3-phosphate by fructose-I, 6-bispho-
sphate is catalyzed by aldolase. Triosephosphate isomerase 
catalyzes the aldoketose isomerization of these triosephosphates 
and eventually only D-glyccraldehyde-3-phosphate follows the 
glycolytic pathway, by bei ng converted into I J-bisphosphoglye-
Glucose 
ATP\l J He:xokinrue 
ADP 
Glucose·6-phosphate 
1 
Fructose-6-phosphate 
ATP\l J Phosphofructokinase 
ADP 
Fructose-I, 6-bisphosphate 
~e AI~ 
D-glyceraJdehyde· Tr/i1sc;:.,hosphe,[e isomerase Dihydroxyacetone 
3·phosphate (<4l!-ller-m-ed-;a-te-: -T'-iO-se-. -1,-2-.e-ne-d-;o-1.-J-'P-ho-sp-h-a-re+) phosphate 
'\fello'lgiYOXa~ . 4011laneous 
synthase " \~PJ---/ ~t" 
:'\Iethylglyoxal + Dopamine _ ADTIQ 
Figure 6. f'ormation of the ncurotoxin l.aectyl·6.7.dihydroxy·1.2.3A·letra-
hydroisoquinolinc (ADTIQ) in the abnormal glucose mctabolism pathway. 
In this pathway. dihydroxyacetone phosphate and 
phosphate are formed from fructose·1.6-bisphosphatc catalyzed by aldolase. 
Triosephosphatc isoillcrase catalyzes aldoketosc isomerization of 
trioscphosphates. Triose 1.2-encdiol-3-phosphate. as an intermediate hctwcell 
dihydroxyacetollc phosphate and is an 
unstable Illolecule which converts into ll1ethylglyoxal. 
be formed from l)·glyceraldehydc·3·phosphatc catalyzed hy 
synthase. MethyJglyoxaJ is an important byproduct which is increased due 
hypergJycaemia in the pathway .. ADTIQ is produced when dopamine 
with mcthylglyoxal. 
crate in a reaction catalyzed by D-glyceraldehyde-3-phosphate 
dehydrogenase (23). Htme\er, triose phosphates arc 
molecules and L-elimination reactions of the phosphoryJ 
from the common 1.2-cnediolatc of both trioses may occur, 
leading to MG formation (24.25). This is a 
parametabol ic reaction and therefore MG occurrence is an 
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unavoidable consequence of glycolytic metabolism (26). MG 
can also be formed from the leakage of the 1,2-enediolate inter-
mediate in the active center of triosephosphate isomerase in a 
paracatalytic reaction (27). Consequently, ADTIQ is produced 
when DA reacts with MG (Fig. 6). 
As previously demonstrated, reactive oxygen species 
(ROS) induced by high glucose levels are involved in vivo in 
both death receptor- and mitochondrial-dependent apoptosis 
of the nervous system (28). Antioxidants may be a therapeutic 
option for preventing cardiovascular damage in patients with 
DM. ROS has been shown to be involved in collagen-induced 
platelet activation and aggregation (29). 
In the SH-SY5Y cell model of hyperglycemia, a large 
amount of free radicals was generated during the course of 
treatment with high glucose, consistent with the observation 
that ROS generation and elimination systems were imbal-
anced under hyperglycemic conditions . Intracellular ROS 
and hydroxyl radical accumulation induced lipid peroxidation 
(LPO) (30); thus, lipid molecules were consumed uninter-
ruptedly, decreasing the amount of unsaturated fatty acid and 
affecting the fluidity of biological membranes (31). MG and 
other aldehydes react with proteins and enzymes, which cause 
them to lose their biological activity and lead to an abnormal 
metabolism. Specifically, MG reacts with DA to form ADTIQ, 
which confirms the hypothesis that CIQs induce a 'vicious' 
cycle of oxidative stress. 
In the present study, compared with the control group, the 
ADTIQ levels in the brains of rats with diabetes were found 
to be sign ificantly elevated (p<O.OI). We also demonstrated 
that the levels of 7 key enzymes from the glycolytic pathway 
were increased significantly in the brains of rats with diabetes. 
More precisely, the expression levels of fructose-bisphosphate 
aldolase and triosephosphate isomerase were higher, suggesting 
that hyperglycemia enhanced the concentration of dihydroxy-
acetone phosphate and D-glyceraldehyde-3-phosphate, thus 
leading to an increase in MG and ADTIQ levels . When ADTIQ 
accumulated and reached a critical level, it damaged neurons 
and induced oxidative stress and apoptosis. Our results also 
indicated that SOD and ATP synthase protein levels were 
significantly reduced in the rats with diabetes. SOD is a potent 
antioxidant enzyme which exerts its effects by scavenging 
ROS. There are data suggesting that elevated glucose levels 
serve as a causal link between the mitochondrial hypergly-
cemia-induced overproduction of superoxide and each of the 
three major pathways responsible for hyperglycemic vascular 
damage caused to endothelial cells (32,33). It has previously 
been demonstrated that the C-peptide has a preventative 
effect on neuronal hippocampal apoptosis in type 1 diabetes, 
although it does not have any effect on oxidative stress (34,35). 
These results indicate that hyperglycemic conditions may 
reduce the activity of SOD; however, the mechanisms involved 
remain unclear. The decreased levels of ATP synthase suggest 
that hyperglycemic conditions may induce mitochondrial 
dysfunction and thus lead to the apoptosis of neuronal cells. 
However, it is evident that multiple factors are involved in the 
progression from diabetes to PD. 
In conclusion, the present study demonstrates that ADTIQ 
may be a type of endogenous neurotoxin and is found in the 
brains of rats with diabetes. We also provide evidence in 
support of the existence of a 'vicious' cycle of oxidative stress. 
The ac;.cumulation of ADTIQ in diabetes be an important 
factor in the connection between diabetes and PD. 
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